GlassScriptPhysician profile
Shilpa Malik
NPI 1316280142
$662.12
in general payments reported to CMS, 2019-2025
17 companies · $20.44 in 2025
The $20.44 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.20 · 2020: $81.43 · 2021: $124 · 2022: $29.29 · 2023: $145 · 2024: $219 · 2025: $20.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $384.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $112.08 | 2021-2024 | |
| Glaxosmithkline, LLC. | $76.53 | 2021-2024 | Nucala |
| Stryker Corporation | $53.58 | 2019-2023 | Xpress Ent Dilation System |
| Genzyme Corporation | $53.17 | 2023-2024 | |
| Aerin Medical INC. | $44.35 | 2024-2025 | |
| Smith+Nephew, INC. | $44.32 | 2020-2021 | |
| Karl Storz Endoscopy-America | $33.75 | 2021 | |
| Medtronic USA, INC. | $33.74 | 2019-2020 | |
| Greer Laboratories, INC. | $33.26 | 2024 | Oralair |
| Medtronic, INC. | $31.76 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.74 | 2023 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $30.16 | 2024 | Dupixent |
| Kaleo, INC. | $21.80 | 2020 | |
| Zoll Respicardia, INC. | $19.87 | 2024 | Remede System |
| Merck Sharp & Dohme LLC | $15.59 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $15.06 | 2023 | Inspire |
| Acclarent, INC | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shilpa Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.